8 min read

Stock Market News — November 16, 2026 — Morning Update — Last 12 Hours (Pacific Time)

Jensen Huang's departure from Nvidia triggered a brutal AI and semiconductor selloff, with Taiwan stocks plunging 5.74% and crypto sliding below $65,000. Bright spots included Telus surging 29% on a Québecor takeover bid and Tyson Foods jumping on improving beef results, but bearish sentiment domina

Executive Summary

The dominant story of the morning is the ongoing fallout from Jensen Huang's departure from Nvidia, which triggered a broad AI and semiconductor selloff across global markets — from Taiwan's 5.74% plunge to widespread declines in U.S. chip names ahead of Nvidia's earnings report Tuesday. Adding to the turbulence, Bitcoin's weekend slide below $65,000 dragged crypto-linked equities sharply lower, while European indices closed mostly in the red. Bright spots were few but notable: Telus surged on an unsolicited Québecor takeover bid, Tyson Foods jumped on improving beef results, and Warren Buffett reaffirmed his confidence in Berkshire with a $5.47 billion share donation.


Sentiment Breakdown

Sentiment Count Percentage
🟢 Bullish 48 ~22%
🟡 Neutral 31 ~14%
🔴 Bearish 138 ~64%

Net Sentiment: Bearish. The Nvidia leadership crisis, AI sector rotation, crypto selloff, and broad European/Asian market declines overwhelmingly dominate the session's tone.


Top Market-Moving Headlines

🔴 AI/Semiconductors | Nvidia stock falls as Huang exit clouds outlook ahead of earnings
Market Impact: NVDA down over 2% at the open, extending a -27.67% three-month slide. Earnings Tuesday are now the most-watched event of the week, with Melius Research calling it potentially the most important call in the company's history.

🔴 Global Markets | Taiwan stocks lower at close of trade; Taiwan Weighted down 5.74%
Market Impact: The steepest single-market decline of the session, driven by chipmaker exposure to the Nvidia fallout and fears of tightening U.S. chip export restrictions on China.

🔴 Crypto | Crypto stocks slide premarket as Bitcoin selloff continues
Market Impact: Bitcoin slipped to approximately $64,600 over the weekend, dragging Strategy (-8.5%), Coinbase (-7.9%), Robinhood (-6.3%), and Circle Internet (-7.8%) sharply lower in premarket.

🟢 M&A/Telecom | TELUS shares jump 29% as board reviews unsolicited Québecor takeover proposal
Market Impact: One of the largest single-stock moves of the session; Canadian Natural Resources simultaneously announced a $2.53 billion buyout of Advantage Energy, sending that stock up 23%.

🟢 Consumer/Earnings | Tyson Foods shares climb on signs of improving US beef business
Market Impact: Shares climbed ~10% after the meatpacker reported improving beef segment results, offering a rare earnings bright spot in an otherwise risk-off session.

🔴 Semiconductors | U.S. chip stocks slide as traders unwind Nvidia rival bets before earnings
Market Impact: AMD (-4.5%), Applied Materials (-4.7%), Lam Research (-6.2%), SK Hynix (-6.4%), Micron (-5.2%), and TSMC (-5.7%) all fell sharply as traders unwound AI-adjacent positions.

🟢 Politics/Nvidia | Trump backs potential return of Jensen Huang as Nvidia CEO
Market Impact: President Trump publicly said he would welcome Huang's return, amplifying a Silicon Valley petition with significant backing — though at least one analyst called a comeback "unlikely."

🔴 Pharma/Biotech | Summit Therapeutics stock plunges after FDA rejects lung cancer drug
Market Impact: Shares tumbled more than 19% in premarket after the FDA issued a Complete Response Letter, a significant clinical setback.

🟢 M&A/Pharma | J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences
Market Impact: Johnson & Johnson expands its ophthalmology pipeline; deal signals continued Big Pharma appetite for bolt-on biotech acquisitions.

🟢 M&A/Pharma | Lilly to buy Calytrix Bio for up to $1.5 billion in rare blood cancer bet
Market Impact: Eli Lilly adds a rare blood cancer asset, continuing its aggressive pipeline-building strategy beyond GLP-1 drugs.

🔴 Tech/AI | Oracle stock sliding after Bloomberg report
Market Impact: Oracle fell 4.2% in morning trading, hitting $120.09, after a Bloomberg report raised concerns — details ambiguous in available context but contributed to broad tech weakness.

🟢 Banking/M&A | UniCredit wins EU and US approval for Commerzbank acquisition
Market Impact: A landmark cross-border European banking deal clears its final major regulatory hurdles, a significant structural event for European financials.

🔴 Aviation | Top four US airlines face $345 million hit from FAA ground stop, Bernstein estimates
Market Impact: A nationwide FAA ground stop is estimated to cost the four largest U.S. airlines a combined $345 million in earnings; L3Harris (-4%) was blamed by the Transportation Secretary for the disruption.

🟢 Biotech | Lexeo Therapeutics shares surge 25% on interim data for LX2020 gene therapy
Market Impact: Positive interim clinical trial results drove one of the session's strongest biotech moves, highlighting continued investor appetite for gene therapy data.

🟢 Macro/Outlook | Morgan Stanley raises S&P 500 target; Barclays joins at 8,700 by end-2027
Market Impact: Both banks cite earnings growth, lower oil, and AI adoption as tailwinds; Morgan Stanley moved to maximum overweight on global equities in its 2027 outlook.

🟢 Warren Buffett | Warren Buffett donates ~$5.47 billion of Berkshire shares, confidence 'as strong as ever'
Market Impact: The donation and accompanying confidence statement reinforce Berkshire's long-term narrative; no negative signal for BRK shareholders.

🔴 Nvidia/Geopolitics | Trump's Nvidia stake grew to as much as $62 million; Singapore-US discuss Megaspeed scandal
Market Impact: Reports of Trump holding up to $62 million in Nvidia stock raise governance questions; the widening Megaspeed chip-smuggling probe adds geopolitical complexity to the Nvidia story.

🔴 Hong Kong/Property | New World Development shares plunge 47% to record low on $3.2 billion rights issue
Market Impact: A massive, deeply dilutive rights issue crushed the Hong Kong property developer's shares to a record low, adding to China property sector stress signals.

🟢 Fintech | BILL Holdings stock surges ~7% after William Blair upgrade
Market Impact: William Blair lifted its rating citing margin expansion and monetization tailwinds, one of the stronger analyst-driven moves of the session.

🔴 Japan | Japan stocks lower at close; Nikkei 225 down 2.25%
Market Impact: Chipmaker and tech losses drove Japan's benchmark to a significant decline, compounding the Asia-wide AI-sector selloff.


Tickers in Focus

Ticker Price/Change Context
NVDA -2%+ at open; -27.67% over 3 months Jensen Huang departure fallout; earnings Tuesday after close
TU (TELUS) +29% Unsolicited Québecor takeover proposal
AAV (Advantage Energy) +23% Canadian Natural Resources $2.53B buyout deal
TSN (Tyson Foods) +~10% Improving beef business; fiscal earnings beat
LXEO (Lexeo Therapeutics) +25% Positive LX2020 gene therapy interim data
SMMT (Summit Therapeutics) -19%+ premarket FDA Complete Response Letter for lung cancer drug
MSTR (Strategy) -8.5% premarket Bitcoin plunge to ~$64,600
COIN (Coinbase) -7.9% premarket; ~$117.55 Bitcoin selloff; new 52-week low territory
HOOD (Robinhood) -6.3% premarket; ~$72.96 Bitcoin/crypto selloff
AMD -4.5% AI chip sector reversal ahead of Nvidia earnings
AMAT (Applied Materials) -4.7%; session low $346.01 Semiconductor sector selloff
LRCX (Lam Research) -6.2%; ~$212.03 Nvidia fallout; chip sector pressure
MU (Micron) -5.2%; ~$738.25 Broad semiconductor retreat
TSMC -5.7%; ~$2,215 Nvidia CEO departure; chip restriction fears
DELL -6.3%; ~$322.88 AI hardware selloff
ORCL -4.2%; ~$120.09 Bloomberg report concerns (details ambiguous)
TSLA -3.4%; session low $376.33 Tech sector selloff; also announced €3B Germany plant expansion
META -2.7%; ~$624.51 Broad tech pullback
BILL +~7% William Blair upgrade on margin/monetization
LLY — Acquiring Calytrix Bio for up to $1.5B
JNJ — Acquiring Ollin Biosciences for $2.2B
TEVA — Settled US states' generic drug price-fixing litigation
ACRS (Aclaris Therapeutics) -8.2%; ~$3.60 Phase 2 atopic dermatitis trial failure
NSIT (Insight Enterprises) -7.8% $650M debt offering plan
BXDC (Blackstone Digital Infrastructure) +6.7%–9.4% $5B AWS deal announced
TTWO (Take-Two Interactive) +4% premarket Jefferies cites strong GTA VI pre-orders
HELP (Helus Pharma) -21%–25% Positive trial results but stock tumbled (market skepticism)
T1 Energy -17.5% New $100M at-the-market equity offering disclosed
CWEN/Cardiff Oncology +~25% FDA Fast Track designation granted
CG Oncology +23.7% premarket Positive topline results announced
Alpha Tau Medical +12.1% premarket Encouraging clinical data disclosed
NVO (Novo Nordisk) +2.4%–2.7%; DKK 286.1 CagriSema REDEFINE 1 Phase 3 data
PLTR (Palantir) -3.3%; ~$162.43 Broad tech selloff
TXN (Texas Instruments) -3.2%; session low $289.59 Sector-wide chip pressure
WDC (Western Digital) -5.3%; ~$280.06 Semiconductor selloff
SK Hynix ADR -6.4%; ~$123.31 AI chip sector reversal
SanDisk -6.1%; ~$831.30 Semiconductor research downgrade
IREN -8.0%; ~$16.71 New 52-week low; AI infrastructure selloff
CoreWeave -7.6% premarket Neocloud sector pressure
Nebius Group -8.6% premarket; ~$105.96 AI cloud selloff
Cerebras Systems -8.1% AI chip sector pressure
VALE ADR -5.0%; ~$10.66 New 52-week low; sharp commodity pressure
L3Harris (LHX) -4% premarket Transportation Secretary blamed firm for aviation chaos
Trump Media (DJT) Near record lows Faces possible $1B convertible debt repayment demand
Peabody Energy +0.9%; ~$17.57 High-profile analyst upgrade
Humana +2.2% premarket RBC Capital upgrade to Outperform
HubSpot +4.2% premarket CEO insider purchase disclosed via Form 4
Xpeng +2.6% premarket Published positive EV delivery/operational data
Tata Motors -8.4%; ~₹430.35 JLR margin cut and restructuring costs
New World Development -47% to record low $3.2B rights issue announced
Costco +0.6% premarket; ~$1,112.28 New 52-week high touched

Market Implications

The Nvidia earnings report Tuesday after the close is the single most consequential near-term catalyst for global markets. With the stock down nearly 28% over three months and Jensen Huang's departure still fresh, the results — and particularly the tone of the leadership transition — will either stabilize or accelerate the AI sector unwind that has already spread from Taiwan to Europe. Traders unwinding "Nvidia rival" positions in AMD, Lam Research, Applied Materials, and TSMC suggest the market is not yet comfortable buying the dip ahead of the print.

The crypto-to-tech contagion is a notable risk signal. Bitcoin's weekend drop to ~$64,600 didn't stay contained to pure-play crypto names — it cascaded into fintech (Robinhood, Circle Internet), AI infrastructure (CoreWeave, Nebius), and even broader sentiment. This interconnectedness between crypto prices and AI/tech valuations reflects how much speculative capital has been deployed across both themes simultaneously. A further Bitcoin leg down could amplify tech selling pressure.

On the constructive side, the M&A pipeline remains active — J&J, Eli Lilly, Canadian Natural Resources, Québecor, UniCredit, Apollo, and BC Partners all announced deals or investments today. This suggests corporate balance sheets remain healthy and strategic buyers see value even amid the selloff. JPMorgan and Morgan Stanley both published bullish 2027 outlooks (S&P 500 target of 8,700 from both Barclays and Morgan Stanley), providing a longer-term counterweight to the current volatility. The key question is whether Nvidia's earnings can serve as a circuit breaker for the AI selloff this week.


Key Takeaways

  • NVDA: Down 28% over three months with Huang gone — Tuesday's earnings call is the most important near-term event for the entire AI trade.
  • Jensen Huang: Trump publicly backed his return; Silicon Valley petition gaining traction; at least one analyst calls a comeback "unlikely."
  • Taiwan Weighted Index: -5.74% — the worst single-market decline of the session, a direct read-through of global chip sector fear.
  • Bitcoin: Weekend drop to ~$64,600 triggered a cascade across crypto stocks, fintech, and AI infrastructure names.
  • TELUS (TU): +29% on unsolicited Québecor takeover bid — one of the biggest M&A surprises of the morning.
  • Advantage Energy (AAV): +23% on Canadian Natural Resources' $2.53B buyout — Canadian energy M&A heating up.
  • Tyson Foods (TSN): +~10% on improving beef business — a rare earnings winner in a risk-off session.
  • Lexeo Therapeutics (LXEO): +25% on LX2020 gene therapy data — biotech catalyst trades alive and well.
  • Summit Therapeutics (SMMT): -19%+ after FDA rejection of lung cancer drug — binary biotech risk on full display.
  • Eli Lilly: Acquiring Calytrix Bio for up to $1.5B, expanding beyond GLP-1 into rare blood cancers.
  • J&J: $2.2B deal for Ollin Biosciences signals continued Big Pharma ophthalmology buildout.
  • Morgan Stanley + Barclays: Both set S&P 500 target at 8,700 for end-2027, citing earnings growth and AI adoption — bullish long-term framing.
  • UniCredit/Commerzbank: EU and US regulatory approvals secured — landmark European banking consolidation deal crosses the finish line.
  • New World Development: -47% to record low on $3.2B rights issue — Hong Kong property stress is not over.
  • Trump Media (DJT): Faces possible $1B convertible debt repayment as stock nears record lows — financial pressure mounting.
  • L3Harris (LHX): -4% after Transportation Secretary publicly blamed the firm for U.S. aviation chaos — reputational and contract risk elevated.
  • Hedge funds: Sold U.S. equities for a second consecutive week (fifth time in six weeks) — institutional positioning remains cautious.
  • Warren Buffett: Donated ~$5.47B in Berkshire shares while reaffirming confidence — no negative signal for BRK holders.
  • BILL Holdings: +~7% on William Blair upgrade — margin expansion and monetization story resonating with analysts.
  • Nvidia "national champions": Trump administration reportedly plans to designate Nvidia and others as AI national champions — a potential policy tailwind if confirmed.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/